乐普医疗
(300003)
| 流通市值：200.55亿 | | | 总市值：233.38亿 |
| 流通股本：16.16亿 | | | 总股本：18.81亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,785,471,627.57 | 3,383,886,554.54 | 1,922,028,839.15 | 7,979,899,319.74 |
| 营业收入 | 4,785,471,627.57 | 3,383,886,554.54 | 1,922,028,839.15 | 7,979,899,319.74 |
| 二、营业总成本 | 3,880,756,982.24 | 2,586,484,750.06 | 1,336,348,890 | 6,354,887,008.61 |
| 营业成本 | 1,780,228,328.8 | 1,207,881,959.38 | 636,463,766.47 | 2,853,285,885.47 |
| 税金及附加 | 58,830,236.87 | 44,492,993.66 | 24,345,130.02 | 96,814,482.11 |
| 销售费用 | 973,676,025.69 | 649,472,497.84 | 334,350,310.5 | 1,624,613,745.79 |
| 管理费用 | 476,245,778.76 | 314,234,119.66 | 142,934,575.75 | 815,825,521.24 |
| 研发费用 | 557,054,487.38 | 356,150,203.71 | 197,385,261.91 | 879,418,426.88 |
| 财务费用 | 34,722,124.74 | 14,252,975.81 | 869,845.35 | 84,928,947.12 |
| 其中:利息费用 | 128,195,183.8 | 87,167,026.14 | 42,207,977.95 | 170,645,096.13 |
| 其中:利息收入 | 84,464,783.54 | 58,107,580.3 | 29,411,929.4 | 115,343,171.74 |
| 加:公允价值变动收益 | -11,199,598.89 | 7,178,523.94 | 3,416,117.92 | 3,091,760.83 |
| 加:投资收益 | -11,713,964.66 | -19,590,896.79 | -4,292,647.74 | -16,533,187.83 |
| 资产处置收益 | 12,365,443.28 | 11,847,502.27 | -400,599.42 | -4,072,105.04 |
| 资产减值损失(新) | -19,285,127.32 | -18,401,396.19 | -328,202.44 | -165,092,450.49 |
| 信用减值损失(新) | -20,531,077.42 | -16,923,707.26 | 3,627,336.5 | -29,870,886.49 |
| 其他收益 | 56,393,787.57 | 40,455,960.53 | 21,519,244.45 | 134,679,694.05 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 910,744,107.89 | 801,967,790.98 | 609,221,198.42 | 1,547,215,136.16 |
| 加:营业外收入 | 12,077,822.49 | 8,181,536.72 | 7,129,312.85 | 44,388,686.76 |
| 减:营业外支出 | 19,914,620.43 | 14,122,503.19 | 9,139,008.43 | 37,105,865.43 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 902,907,309.95 | 796,026,824.51 | 607,211,502.84 | 1,554,497,957.49 |
| 减:所得税费用 | 119,559,657.34 | 106,018,680.32 | 114,450,959.38 | 262,147,007.11 |
| 六、净利润 | 783,347,652.61 | 690,008,144.19 | 492,760,543.46 | 1,292,350,950.38 |
| 持续经营净利润 | 783,347,652.61 | 690,008,144.19 | 492,760,543.46 | 1,292,350,950.38 |
| 归属于母公司股东的净利润 | 802,655,886.18 | 697,242,271.91 | 481,871,134.58 | 1,258,200,337.67 |
| 少数股东损益 | -19,308,233.57 | -7,234,127.72 | 10,889,408.88 | 34,150,612.71 |
| (一)基本每股收益 | 0.43 | 0.38 | 0.26 | 0.68 |
| (二)稀释每股收益 | 0.43 | 0.38 | 0.26 | 0.68 |
| 八、其他综合收益 | -9,909,358.96 | -115,074,143.11 | -8,798,240.24 | 63,426,376.92 |
| 归属于母公司股东的其他综合收益 | 7,488,657.4 | -98,317,628.09 | -2,883,682.58 | 86,636,084.31 |
| 九、综合收益总额 | 773,438,293.65 | 574,934,001.08 | 483,962,303.22 | 1,355,777,327.3 |
| 归属于母公司股东的综合收益总额 | 810,144,543.58 | 598,924,643.82 | 478,987,452 | 1,344,836,421.98 |
| 归属于少数股东的综合收益总额 | -36,706,249.93 | -23,990,642.74 | 4,974,851.22 | 10,940,905.32 |
| 公告日期 | 2024-10-26 | 2024-08-24 | 2024-04-20 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |